PSD2
PH and SEC7 domain-containing protein 2
Also known as: DKFZp761B0514, EFA6C, PSD2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQI7
- Gene
- PSD2
- Ensembl
- ENSG00000146005
- Chromosome
- 5
- Canonical length
- 771 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Predicted to enable guanyl-nucleotide exchange factor activity and phospholipid binding activity. Predicted to be involved in regulation of ARF protein signal transduction. Predicted to be located in cleavage furrow and ruffle membrane. Predicted to be active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
771 residues, UniProt reviewed canonical sequence.
>Q9BQI7|PSD2
1 MEEDKLLSAV PEEGDATRDP GPEPEEEPGV RNGMASEGLN SSLCSPGHER RGTPADTEEP
61 TKDPDVAFHG LSLGLSLTNG LALGPDLNIL EDSAESRPWR AGVLAEGDNA SRSLYPDAED
121 PQLGLDGPGE PDVRDGFSAT FEKILESELL RGTQYSSLDS LDGLSLTDES DSCVSFEAPL
181 TPLIQQRARD SPEPGAGLGI GDMAFEGDMG AAGGDGELGS PLRRSISSSR SENVLSRLSL
241 MAMPNGFHED GPQGPGGDED DDEEDTDKLL NSASDPSLKD GLSDSDSELS SSEGLEPGSA
301 DPLANGCQGV SEAAHRLARR LYHLEGFQRC DVARQLGKNN EFSRLVAGEY LSFFDFSGLT
361 LDGALRTFLK AFPLMGETQE RERVLTHFSR RYCQCNPDDS TSEDGIHTLT CALMLLNTDL
421 HGHNIGKKMS CQQFIANLDQ LNDGQDFAKD LLKTLYNSIK NEKLEWAIDE DELRKSLSEL
481 VDDKFGTGTK KVTRILDGGN PFLDVPQALS ATTYKHGVLT RKTHADMDGK RTPRGRRGWK
541 KFYAVLKGTI LYLQKDEYRP DKALSEGDLK NAIRVHHALA TRASDYSKKS NVLKLKTADW
601 RVFLFQAPSK EEMLSWILRI NLVAAIFSAP AFPAAVSSMK KFCRPLLPSC TTRLCQEEQL
661 RSHENKLRQL TAELAEHRCH PVERGIKSKE AEEYRLKEHY LTFEKSRYET YIHLLAMKIK
721 VGSDDLERIE ARLATLEGDD PSLRKTHSSP ALSQGHVTGS KTTKDATGPD TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 82 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 82 nTPM
- cerebral cortex: 58 nTPM
- amygdala: 57 nTPM
- midbrain: 55 nTPM
- hypothalamus: 45 nTPM
- cerebellum: 40 nTPM
Single-cell type
- astrocytes: 253 nCPM
- ependymal cells: 128 nCPM
- bergmann glia: 124 nCPM
- oligodendrocyte progenitor cells: 66 nCPM
- other brain neurons: 15 nCPM
- retinal amacrine cells: 11 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 208 nTPM
- midbrain: 203 nTPM
- medulla oblongata: 171 nTPM
- basal ganglia: 170 nTPM
- cerebellum: 162 nTPM
- pons: 148 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSD2 as an antibody target. Whether an autoantibody or antibody against PSD2 could matter depends on whether native PSD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSD2 is annotated at the cell surface, where native PSD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PSD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...